Prognostic impact of dose to circulating blood cells in non-small cell lung cancer patients after chemoradiotherapy.

Transl Lung Cancer Res · 2025 · PMC12541861 · PMID 41132998

Europe PMC DOI

hedged sentences

0.0200

closest p · 0.4× alpha

0.0900

boldest claim

The sentences

borderline significanceP=0.02actually significant

Baseline ALC demonstrated borderline significance with an OR close to 1 (OR: 0.999, 95% CI: 0.999–1.000, P=0.02).

also in 7,017 other papers

marginal significanceP=0.09so close (0.05 < p ≤ 0.1)

The EDIC demonstrated marginal significance in predicting SRIL (OR =1.236, P=0.09), but this association was not maintained after FDR correction (FDR =0.12).

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.